Delivery Order SPE2DR25D3501-SPE2DR26FL9BK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,889.09 to AmerisourceBergen Drug Corp for 40,000 units/mL of Procrit (epoetin alfa), a pharmaceutical used to treat anemia. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance....
- The Defense Logistics Agency awarded a $3,881.47 firm fixed price delivery order to AmerisourceBergen Drug Corp for 40,000 units/mL of Procrit (epoetin alfa), a pharmaceutical used to treat anemia. The award, issued on September 12, 2025, is a non-set-aside competitive contract with an ultimate completion date of September 15, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $12,414.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit (epoetin alfa), a medication used to treat anemia. The order was placed on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's qualification to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,075.68 to AmerisourceBergen Drug Corp for 40,000 units/ml of Procrit (epoetin alfa), a pharmaceutical used to treat anemia. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procrit 10,000 units/ml vials valued at $5,089.52. This firm fixed-price delivery order is set to be completed by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 40,000 units/mL of the medication Procrit. The contract has a ceiling value of $1,144.26 and an ultimate completion date of November 7, 2024. It is a firm fixed-price contract type. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen is a for-profit...
- Amerisourcebergen Drug Corporation has been awarded a $201 firm fixed price delivery order against an unidentified multiple award contract vehicle by the Defense Logistics Agency Troop Support Medical. The order is for 2,000 units/ml vials of epoetin alfa, marketed as Procrit, to be delivered to a location in Conshohocken, Pennsylvania by October 17, 2023. No set aside designation was applied to this procurement. The Defense Logistics Agency Troop Support Medical supports the healthcare needs of...
- This federal contract award, valued at $8,795.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 40,000 units of Procrit (Epoetin alfa), a medication used to treat anemia. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves...
- The Defense Logistics Agency Troop Support Medical awarded a $5,085.82 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 40,000 units per milliliter vials of PROCRIT. Place of performance will be in Conshohocken, Pennsylvania, with work occurring between July 14-17, 2023. The delivery order was issued against an unspecified multiple award contract vehicle to supply the critical anemia drug PROCRIT in support of the Defense Logistics Agency's medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,348.46 contract is for the supply of 20,000 units of the medication PROCRIT (2 mL vials) with a completion date of May 19, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9BKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,360.04 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Procrit (epoetin alfa) 10,000 units/mL vials. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Procrit is a widely-used erythropoiesis-stimulating agent commonly prescribed for anemia management in healthcare settings. This delivery order represents a routine fulfillment under AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support defense health operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/20/25 |